This report contains market size and forecasts of Soft Tissue Sarcoma Drugs in Global, including the following market information:
Global Soft Tissue Sarcoma Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Soft Tissue Sarcoma Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Local Sarcoma Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Soft Tissue Sarcoma Drugs include Roche, Pfizer, Johnson & Johnson, GSK Plc, Teva Pharmaceuticals, Celgene, Bristol Myers Squibb, BeiGene and Shenzhen Chipscreen, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Soft Tissue Sarcoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Soft Tissue Sarcoma Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Soft Tissue Sarcoma Drugs Market Segment Percentages, by Type, 2022 (%)
Local Sarcoma
Metastatic Sarcoma
Other Sarcoma
Global Soft Tissue Sarcoma Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Soft Tissue Sarcoma Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Oncology Centers
Other
Global Soft Tissue Sarcoma Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Soft Tissue Sarcoma Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Soft Tissue Sarcoma Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Soft Tissue Sarcoma Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Pfizer
Johnson & Johnson
GSK Plc
Teva Pharmaceuticals
Celgene
Bristol Myers Squibb
BeiGene
Shenzhen Chipscreen
Monopar Therapeutics
Akeso Biopharma
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Soft Tissue Sarcoma Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Soft Tissue Sarcoma Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Soft Tissue Sarcoma Drugs Overall Market Size
2.1 Global Soft Tissue Sarcoma Drugs Market Size: 2022 VS 2030
2.2 Global Soft Tissue Sarcoma Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Soft Tissue Sarcoma Drugs Players in Global Market
3.2 Top Global Soft Tissue Sarcoma Drugs Companies Ranked by Revenue
3.3 Global Soft Tissue Sarcoma Drugs Revenue by Companies
3.4 Top 3 and Top 5 Soft Tissue Sarcoma Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Soft Tissue Sarcoma Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Soft Tissue Sarcoma Drugs Players in Global Market
3.6.1 List of Global Tier 1 Soft Tissue Sarcoma Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Soft Tissue Sarcoma Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Soft Tissue Sarcoma Drugs Market Size Markets, 2022 & 2030
4.1.2 Local Sarcoma
4.1.3 Metastatic Sarcoma
4.1.4 Other Sarcoma
4.2 By Type - Global Soft Tissue Sarcoma Drugs Revenue & Forecasts
4.2.1 By Type - Global Soft Tissue Sarcoma Drugs Revenue, 2018-2023
4.2.2 By Type - Global Soft Tissue Sarcoma Drugs Revenue, 2023-2030
4.2.3 By Type - Global Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Soft Tissue Sarcoma Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Oncology Centers
5.1.4 Other
5.2 By Application - Global Soft Tissue Sarcoma Drugs Revenue & Forecasts
5.2.1 By Application - Global Soft Tissue Sarcoma Drugs Revenue, 2018-2023
5.2.2 By Application - Global Soft Tissue Sarcoma Drugs Revenue, 2023-2030
5.2.3 By Application - Global Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Soft Tissue Sarcoma Drugs Market Size, 2022 & 2030
6.2 By Region - Global Soft Tissue Sarcoma Drugs Revenue & Forecasts
6.2.1 By Region - Global Soft Tissue Sarcoma Drugs Revenue, 2018-2023
6.2.2 By Region - Global Soft Tissue Sarcoma Drugs Revenue, 2023-2030
6.2.3 By Region - Global Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Soft Tissue Sarcoma Drugs Revenue, 2018-2030
6.3.2 US Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.3.3 Canada Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.3.4 Mexico Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Soft Tissue Sarcoma Drugs Revenue, 2018-2030
6.4.2 Germany Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4.3 France Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4.4 U.K. Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4.5 Italy Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4.6 Russia Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.4.8 Benelux Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Soft Tissue Sarcoma Drugs Revenue, 2018-2030
6.5.2 China Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.5.3 Japan Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.5.4 South Korea Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.5.6 India Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Soft Tissue Sarcoma Drugs Revenue, 2018-2030
6.6.2 Brazil Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.6.3 Argentina Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Soft Tissue Sarcoma Drugs Revenue, 2018-2030
6.7.2 Turkey Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.7.3 Israel Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Soft Tissue Sarcoma Drugs Market Size, 2018-2030
6.7.5 UAE Soft Tissue Sarcoma Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Soft Tissue Sarcoma Drugs Major Product Offerings
7.1.4 Roche Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Soft Tissue Sarcoma Drugs Major Product Offerings
7.2.4 Pfizer Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Soft Tissue Sarcoma Drugs Major Product Offerings
7.3.4 Johnson & Johnson Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News
7.4 GSK Plc
7.4.1 GSK Plc Corporate Summary
7.4.2 GSK Plc Business Overview
7.4.3 GSK Plc Soft Tissue Sarcoma Drugs Major Product Offerings
7.4.4 GSK Plc Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.4.5 GSK Plc Key News
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Corporate Summary
7.5.2 Teva Pharmaceuticals Business Overview
7.5.3 Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Major Product Offerings
7.5.4 Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceuticals Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Soft Tissue Sarcoma Drugs Major Product Offerings
7.6.4 Celgene Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.6.5 Celgene Key News
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Corporate Summary
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Soft Tissue Sarcoma Drugs Major Product Offerings
7.7.4 Bristol Myers Squibb Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.7.5 Bristol Myers Squibb Key News
7.8 BeiGene
7.8.1 BeiGene Corporate Summary
7.8.2 BeiGene Business Overview
7.8.3 BeiGene Soft Tissue Sarcoma Drugs Major Product Offerings
7.8.4 BeiGene Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.8.5 BeiGene Key News
7.9 Shenzhen Chipscreen
7.9.1 Shenzhen Chipscreen Corporate Summary
7.9.2 Shenzhen Chipscreen Business Overview
7.9.3 Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Major Product Offerings
7.9.4 Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.9.5 Shenzhen Chipscreen Key News
7.10 Monopar Therapeutics
7.10.1 Monopar Therapeutics Corporate Summary
7.10.2 Monopar Therapeutics Business Overview
7.10.3 Monopar Therapeutics Soft Tissue Sarcoma Drugs Major Product Offerings
7.10.4 Monopar Therapeutics Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.10.5 Monopar Therapeutics Key News
7.11 Akeso Biopharma
7.11.1 Akeso Biopharma Corporate Summary
7.11.2 Akeso Biopharma Business Overview
7.11.3 Akeso Biopharma Soft Tissue Sarcoma Drugs Major Product Offerings
7.11.4 Akeso Biopharma Soft Tissue Sarcoma Drugs Revenue in Global Market (2018-2023)
7.11.5 Akeso Biopharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Soft Tissue Sarcoma Drugs Market Opportunities & Trends in Global Market
Table 2. Soft Tissue Sarcoma Drugs Market Drivers in Global Market
Table 3. Soft Tissue Sarcoma Drugs Market Restraints in Global Market
Table 4. Key Players of Soft Tissue Sarcoma Drugs in Global Market
Table 5. Top Soft Tissue Sarcoma Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Soft Tissue Sarcoma Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Soft Tissue Sarcoma Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Soft Tissue Sarcoma Drugs Product Type
Table 9. List of Global Tier 1 Soft Tissue Sarcoma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Soft Tissue Sarcoma Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Soft Tissue Sarcoma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Soft Tissue Sarcoma Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Soft Tissue Sarcoma Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Soft Tissue Sarcoma Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Soft Tissue Sarcoma Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Soft Tissue Sarcoma Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2023-2030
Table 30. Roche Corporate Summary
Table 31. Roche Soft Tissue Sarcoma Drugs Product Offerings
Table 32. Roche Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Soft Tissue Sarcoma Drugs Product Offerings
Table 35. Pfizer Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Soft Tissue Sarcoma Drugs Product Offerings
Table 38. Johnson & Johnson Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 39. GSK Plc Corporate Summary
Table 40. GSK Plc Soft Tissue Sarcoma Drugs Product Offerings
Table 41. GSK Plc Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Teva Pharmaceuticals Corporate Summary
Table 43. Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Product Offerings
Table 44. Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Celgene Corporate Summary
Table 46. Celgene Soft Tissue Sarcoma Drugs Product Offerings
Table 47. Celgene Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Bristol Myers Squibb Corporate Summary
Table 49. Bristol Myers Squibb Soft Tissue Sarcoma Drugs Product Offerings
Table 50. Bristol Myers Squibb Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 51. BeiGene Corporate Summary
Table 52. BeiGene Soft Tissue Sarcoma Drugs Product Offerings
Table 53. BeiGene Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Shenzhen Chipscreen Corporate Summary
Table 55. Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Product Offerings
Table 56. Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 57. Monopar Therapeutics Corporate Summary
Table 58. Monopar Therapeutics Soft Tissue Sarcoma Drugs Product Offerings
Table 59. Monopar Therapeutics Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Akeso Biopharma Corporate Summary
Table 61. Akeso Biopharma Soft Tissue Sarcoma Drugs Product Offerings
Table 62. Akeso Biopharma Soft Tissue Sarcoma Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Soft Tissue Sarcoma Drugs Segment by Type in 2022
Figure 2. Soft Tissue Sarcoma Drugs Segment by Application in 2022
Figure 3. Global Soft Tissue Sarcoma Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Soft Tissue Sarcoma Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Soft Tissue Sarcoma Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Soft Tissue Sarcoma Drugs Revenue in 2022
Figure 8. By Type - Global Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 12. US Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 24. China Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Soft Tissue Sarcoma Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Soft Tissue Sarcoma Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. Roche Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Pfizer Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Johnson & Johnson Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. GSK Plc Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BeiGene Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Monopar Therapeutics Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Akeso Biopharma Soft Tissue Sarcoma Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
